LEMAITRE VASCULAR, INC. Restructuring Charges
LEMAITRE VASCULAR, INC. (LMAT) reported Restructuring Charges of $3.10 million for the 12-month period ending 2022-12-31, per its 10-Q filed 2024-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2024-08-08
- LEMAITRE VASCULAR, INC. restructuring charges for the quarter ending 2022-06-30 was $3.10M.
- LEMAITRE VASCULAR, INC. restructuring charges for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- LEMAITRE VASCULAR, INC. restructuring charges for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- LEMAITRE VASCULAR, INC. restructuring charges for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- LEMAITRE VASCULAR, INC. restructuring charges for fiscal 2014 was $526.00K.
- LEMAITRE VASCULAR, INC. restructuring charges for fiscal 2011 was $2.16M, a 19.00% increase from fiscal 2010.
- LEMAITRE VASCULAR, INC. restructuring charges for fiscal 2010 was $1.82M, a 2.19% increase from fiscal 2009.
- LEMAITRE VASCULAR, INC. restructuring charges for fiscal 2009 was $1.78M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2022-12-31 | $3.10M 10-Q · filed 2024-08-08 | |||
| 2022-06-30 | $3.10M 10-Q · filed 2022-11-08 | $3.10M 10-Q · filed 2022-11-08 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $0.00 derived: sum of 2 quarters · filed 2015-11-06 | $0.00 10-Q · filed 2015-11-06 | $26.00K derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | $26.00K derived: sum of 3 quarters · filed 2017-03-09 | $34.00K derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-07 | $26.00K derived: sum of 2 quarters · filed 2017-03-09 | $34.00K derived: sum of 3 quarters · filed 2017-03-09 | $123.00K derived: sum of 4 quarters · filed 2017-03-09 |
| 2014-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $34.00K derived: sum of 2 quarters · filed 2017-03-09 | $123.00K derived: sum of 3 quarters · filed 2017-03-09 | $526.00K 10-K · filed 2017-03-09 |
| 2014-09-30 | $8.00K 10-Q · filed 2015-11-06 | $97.00K derived: sum of 2 quarters · filed 2015-11-06 | $500.00K 10-Q · filed 2015-11-06 | |
| 2014-06-30 | $89.00K 10-Q · filed 2015-08-06 | $492.00K 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | $403.00K 10-Q · filed 2015-05-07 | |||
| 2011-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $506.00K derived: sum of 2 quarters · filed 2014-03-21 | $1.16M derived: sum of 3 quarters · filed 2014-03-21 | $2.16M 10-K · filed 2014-03-21 |
| 2011-09-30 | $394.00K 10-Q · filed 2012-11-09 | $1.04M derived: sum of 2 quarters · filed 2012-11-09 | $2.05M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $650.00K 10-Q · filed 2012-08-10 | $1.66M 10-Q · filed 2012-08-10 | ||
| 2011-03-31 | $1.00M 10-Q · filed 2012-05-03 | |||
| 2010-12-31 | $1.82M 10-K · filed 2013-03-27 | |||
| 2009-12-31 | $1.78M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |